Abiopharma

Business Update

Response to Questions received from Shareholders and SIAS for the Annual General Meeting

Change - Announcement of Appointment :: Appointment of Ms. Chen Xiaoling as Group Chief Executive Officer ("CEO") and Singapore CEO.

Scilex Holding Company Announces Publication onGLOPERBA® Dosing Adjustments in Peer-Review Journal

Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®

The latest from NRC Health | Meet NRC Healths new CEO, preview HUB25s concurrent sessions, and so much more!

Merus N.V. annonce la fixation du prix de l’offre publique d’actions ordinaires

Merus N.V. gibt Preis für öffentliches Angebot von Stammaktien bekannt

CORRECTION - Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

MAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical Trial